<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04872842</url>
  </required_header>
  <id_info>
    <org_study_id>82071296</org_study_id>
    <nct_id>NCT04872842</nct_id>
  </id_info>
  <brief_title>Establishment of Online Registration Platform for Unruptured Intracranial Aneurysms Based on 100 Regional Medical Centers in China and Population Follow-up Study</brief_title>
  <official_title>Establishment of Online Registration Platform for Unruptured Intracranial Aneurysms Based on 100 Regional Medical Centers in China and Population Follow-up Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Tiantan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beijing Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Sanbo Brain Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Chao Yang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Binzhou Renmin Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fujian Medical University Union Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital of Fujian Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guangzhou Red Cross Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Haerbin Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Affiliated Hospital of Qingdao University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shaanxi Provincial People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Tsinghua Changgeng Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sichuan Provincial People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wuhan Union Hospital, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Affiliated Hospital of Kunming Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Unimed Technology Company</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Beijing Tiantan Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, 20 regional neurosurgery centers across the country will be included, and the&#xD;
      study cohort will be constructed on the basis of the IARP-CP cohort.The artificial&#xD;
      intelligence platform was used to analyze the clinical, morphological, hemodynamics, aneurysm&#xD;
      wall characteristics and other factors of unruptured aneurysms, as well as the relationship&#xD;
      between these factors and the risk of aneurysm instability, seek the potential risk factors,&#xD;
      and finally establish a multi-dimensional prediction model of rupture risk of intracranial&#xD;
      aneurysms.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2021</start_date>
  <completion_date type="Anticipated">May 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Aneurysm rupture</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Aneurysm growth</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Intracranial Aneurysm</condition>
  <arm_group>
    <arm_group_label>unstable intracranial aneurysms</arm_group_label>
    <description>Unstable intracranial aneurysms are defined as the intracranial aneurysms that grows or ruptures.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>stable intracranial aneurysms</arm_group_label>
    <description>Stable intracranial aneurysms are defined as the intracranial aneurysms that have no significant morphological changes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Obervation</intervention_name>
    <description>This study is an observational study without any intervention</description>
    <arm_group_label>stable intracranial aneurysms</arm_group_label>
    <arm_group_label>unstable intracranial aneurysms</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Chinese&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. 18-75 years old;&#xD;
&#xD;
          2. At least one unruptured intracranial aneurysm was found by CTA;&#xD;
&#xD;
          3. No relevant symptoms, receiving non-operative and conservative observation treatment;&#xD;
&#xD;
          4. Signing the informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Other cerebrovascular structural lesions (such as cerebrovascular malformation and&#xD;
             arteriovenous fistula) or craniocerebral tumors;&#xD;
&#xD;
          2. Fusiform or dissecting aneurysms;&#xD;
&#xD;
          3. Traumatic, mycotic and atrial myxoma associated aneurysms;&#xD;
&#xD;
          4. Suffering from systemic connective tissue diseases, such as polycystic kidney disease;&#xD;
&#xD;
          5. Expectant survival of no more than 3 years due to other diseases or poor general&#xD;
             conditions;&#xD;
&#xD;
          6. Patients refuse to follow up or cannot communicate with them due to mental diseases;&#xD;
&#xD;
          7. Pregnant women or participating in other aneurysm related studies.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Shuo Wang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Tiantan Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Qingyuan Liu, MD</last_name>
    <phone>+8613260457220</phone>
    <email>13260457220@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shuo Wang, MD</last_name>
    <phone>+8613801180330</phone>
    <email>captain9858@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beijing Tiantan Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Qingyuan Liu, MD</last_name>
      <phone>13260457220</phone>
      <email>13260457220@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 22, 2021</study_first_submitted>
  <study_first_submitted_qc>April 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 5, 2021</study_first_posted>
  <last_update_submitted>April 29, 2021</last_update_submitted>
  <last_update_submitted_qc>April 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Tiantan Hospital</investigator_affiliation>
    <investigator_full_name>Wang Shuo</investigator_full_name>
    <investigator_title>Director of Department of Cerebrovascular Neurosurgery</investigator_title>
  </responsible_party>
  <keyword>intracranial aneurysm</keyword>
  <keyword>online registration platform</keyword>
  <keyword>artificial intelligence</keyword>
  <keyword>multidimensional model</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intracranial Aneurysm</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

